(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.16%) $0.928
(0.20%) $10.86
(0.02%) $0.792
(-0.46%) $92.15
Live Chart Being Loaded With Signals
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections...
Stats | |
---|---|
Today's Volume | 84 565.00 |
Average Volume | 179 503 |
Market Cap | 35.45M |
EPS | $-0.380 ( 2024-03-18 ) |
Next earnings date | ( $-0.240 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.13 |
ATR14 | $0.0200 (0.81%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-19 | Sailer Carl | Buy | 19 737 | Common Stock |
2024-01-19 | Sailer Carl | Sell | 19 737 | Warrants for Common Stock |
2021-12-02 | Deluccia Robert J | Sell | 40 000 | Common Stock |
2023-12-12 | Deluccia Robert J | Sell | 40 000 | Common Stock |
2024-01-03 | Deluccia Robert J | Buy | 19 737 | Common Stock |
INSIDER POWER |
---|
38.32 |
Last 58 transactions |
Buy: 2 790 791 | Sell: 229 212 |
Volume Correlation
Acurx Pharmaceuticals, Correlation
10 Most Positive Correlations | |
---|---|
SISI | 0.968 |
GLMD | 0.965 |
PEAR | 0.963 |
GMBL | 0.962 |
PPBT | 0.951 |
LAWS | 0.948 |
ACET | 0.945 |
PTE | 0.944 |
NCBS | 0.944 |
CYTO | 0.942 |
10 Most Negative Correlations | |
---|---|
GXII | -0.969 |
CLBT | -0.961 |
GASS | -0.958 |
ISEE | -0.958 |
RAM | -0.957 |
MITA | -0.957 |
NECB | -0.956 |
IVCB | -0.955 |
AGGR | -0.955 |
CSWC | -0.954 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Acurx Pharmaceuticals, Correlation - Currency/Commodity
Acurx Pharmaceuticals, Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.150 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.380 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.240 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.280 |
Financial Reports:
No articles found.
Acurx Pharmaceuticals,
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators